| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |